<i>In vitro</i> and <i>in vivo</i> identification of clinically approved drugs that modify <i> <scp>ACE</scp> 2 </i> expression
The COVID-19 pandemic caused by SARS-CoV-2 has is a global health challenge. Angiotensin-converting enzyme 2 (ACE2) is the host receptor for SARS-CoV-2 entry. Recent studies have suggested that patients with hypertension and diabetes treated with ACE inhibitors (ACEIs) or angiotensin receptor blocke...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | inglés |
| Publicado: |
2020
|
| Acceso en liña: | https://doi.org/10.15252/msb.20209628 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|